Magloy Tech is an NUS spin-off developing bioresorbable magnesium implants that dissolve naturally after bone healing, eliminating the need for implant-removal surgery. Its flagship product, ResoMag, has completed GLP large-animal preclinical studies and received FDA Q-Sub feedback confirming the 510(k) pathway. With proven biocompatibility and mechanical strength, Magloy Tech is advancing toward regulatory submission and commercialization for trauma and sports medicine applications.